Lanxess Shares Plunge Amid Deepening Profit Crisis

Lanxess announces major restructuring with €100M savings plan and 550 job cuts after a €577M net loss. Shares hit 52-week low as outlook remains cautious.

The specialty chemicals group Lanxess is intensifying its restructuring efforts following a deeply challenging 2025 fiscal year. Confronted with a net loss of 577 million euros and a gloomy outlook, management is being forced to implement drastic measures aimed at stabilizing the company's profitability.

Drastic Cost-Cutting Measures Announced

In response to persistent headwinds, the company has unveiled a significant savings program. The plan targets annual cost reductions of 100 million euros by 2028. As part of this initiative, 550 positions will be eliminated globally, with two-thirds of the job cuts affecting its German sites. Furthermore, Lanxess has agreed to implement a 35-hour work week for employees covered by collective bargaining agreements in a bid to lower fixed costs in the short term.

The group's revenue contracted by nearly eleven percent last year, falling to 5.67 billion euros. Company leadership pointed to sustained weak demand across almost all customer industries and intense pricing pressure from Asian competitors as the primary causes. The sale of business units provided a silver lining, helping to reduce net financial debt to approximately two billion euros.

Cautious Outlook and Market Reaction

Management maintains a subdued outlook for 2026, pinning hopes for a potential recovery on government infrastructure projects expected to provide a stimulus only in the second half of the year. For the current year, adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) is projected to land between 450 and 550 million euros. This mid-point forecast suggests a further decline from an already weak prior-year performance.

The stock's sharp decline in recent weeks has prompted a fresh assessment from market analysts, who are divided on the path to recovery:

• UBS: Sell (Price Target: €14)
• Deutsche Bank: Hold (Price Target: €17)
• mwb research: Buy (Price Target: €17)
• Goldman Sachs: Neutral (Price Target: €23)

Lanxess shares touched a new 52-week low of €11.78 this past Friday. The equity has shed almost 40 percent of its value in the last 30 days alone. Investor attention is now firmly fixed on the company's ability to execute its cost-saving targets consistently and the hoped-for economic revival in late 2026.